© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Peggy Peck
Articles
FDA Expands Hot Dog Chili Sauce Recall to 10 Brands
July 23, 2007
ROCKVILLE, Md. -- Based on botulism toxin tests at an Augusta, Ga., food processing plant, the FDA has expanded its warning about chili dog sauce to include 10 canned sauces and four pet food products.
FDA Expands Chili Sauce Recall to Include Dozens of Related Products
July 23, 2007
ROCKVILLE, Md. -- Based on botulism toxin tests at an Augusta, Ga., food processing plant, the FDA has expanded its warning about chili dog sauce to include 10 canned sauces and four pet food products.
FDA Okays First Artificial Cervical Disc
July 17, 2007
ROCKVILLE, Md. -- The FDA has approved a stainless steel artificial cervical disc for treatment of cervical degenerative disc disease.
FDA Okays Molecular Assay to Detect Node-Positive Breast Cancer
July 16, 2007
ROCKVILLE, Md. -- The FDA has approved GeneSearch BLN assay, a rapid molecular-based assay for detecting node-positive breast cancer.
FDA Approves Bifocal LASIK Surgery
July 12, 2007
ROCKVILLE, Md. -- The FDA has approved a bifocal LASIK approach in which one eye will be treated for myopia and the other presbyopia.
FDA Approves Robotic Arm for Physical Therapy of Stroke Patients
July 12, 2007
BOSTON -- The FDA has okayed use of a strap-on robotic arm to help restore function to an upper-extremity disabled by a stroke, according to the manufacturer.
FDA Approves Rivastigmine Patch for Alzheimer's Disease
July 10, 2007
EAST HANOVER, N.J. -- The FDA has approved a rivastigmine transdermal patch for mild to moderate Alzheimer's disease, Novartis announced here.
FDA Cites Risks of Ceftriaxone (Rocephin) Mixed With Calcium
July 06, 2007
ROCKVILLE, Md. -- Calcium and ceftriaxone (Rocephin) are a dangerous combination that can increase the risk of lethal precipitates forming in the lungs and kidneys of infants, according to the FDA.
CF Death Prompts FDA Alert on Nebulized Liquid Colisthemethate
June 29, 2007
ROCKVILLE, Md. -- The death of cystic fibrosis patient had led the FDA to alert physicians about the risk of prescribing premixed colistimethate for inhalation with a nebulizer.
AMA: Delegates Want Principles First with Pay for Performance
June 27, 2007
CHICAGO -- The American Medical Association wants third-party payers to put the brakes on pay-for-performance initiatives until there is evidence that such plans benefit patients.